Vida Ventures Advisors, LLC
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed October 8, 2024), Vida Ventures Advisors, LLC reported 6 stock positions worth $138.6 million. Its top holding was Centessa Pharmaceuticals (CNTA) at 45.4% of the portfolio, followed by Tectonic Therapeutic (TECX, 22.5%) and Kyverna Therapeutics (KYTX, 16.0%). Compared with Q2 2024, it opened 1 new position. The biggest buy was a new position in Tectonic Therapeutic (TECX).
- Most Recent 13F
- Q3 2025
- Location
- BOSTON, MA
- CIK
- 0001831423
- Portfolio Value
- $138.6M (Q3 2024)
- SEC Filing
- 0000950123-24-009559 ↗ filed Oct 8, 2024
Holdings Value
Holdings 6 stocks · $138.6M
| CNTA Centessa Pharmaceuticals Ltd. | 45.36% | 3,931,818 | $62.9M | No change |
| TECX Tectonic Therapeutic Inc. | 22.49% | 1,028,674 | $31.2M | New |
| KYTX Kyverna Therapeutics Inc. | 15.96% | 4,523,924 | $22.1M | No change |
| DYN Dyne Therapeutics Inc. | 10.56% | 407,499 | $14.6M | No change |
| ALLO Allogene Therapeutics Inc. | 3.63% | 1,798,163 | $5.0M | No change |
| KRON Kronos Bio Inc. | 2.00% | 2,765,314 | $2.8M | No change |
Portfolio Sells Q2 2024 → Q3 2024
| None this quarter. | |||
Portfolio Buys Q2 2024 → Q3 2024
| TECX Tectonic Therapeutic Inc. | New | 22.49% | +22.49 |